Compass Therapeutics, Inc. (CMPX) Insider Trading -- Recent Executive & Director Transactions
4 insiders reported 14 Form 4 transactions for Compass Therapeutics, Inc. (CMPX) over the past 18 months (most recent 2026-10-02). Recent activity: Lerner Neil (Chief Accounting Officer) Buy 20,000 shares, Lerner Neil (Chief Accounting Officer) Buy 2,500 shares, Anderman Jonathan (General Counsel) Buy 25,000 shares, Lerner Neil (Chief Accounting Officer) Buy 15,000 shares, Lerner Neil (Chief Accounting Officer) Buy 15,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Lerner Neil | Chief Accounting Officer | Buy | 20,000 | $18,400 |
| 2026-09-25 | Lerner Neil | Chief Accounting Officer | Buy | 2,500 | $2,850 |
| 2026-04-30 | Anderman Jonathan | General Counsel | Buy | 25,000 | $47,250 |
| 2026-04-30 | Lerner Neil | Chief Accounting Officer | Buy | 15,000 | $28,350 |
| 2026-04-29 | Lerner Neil | Chief Accounting Officer | Buy | 15,000 | $28,350 |
| 2026-04-29 | Anderman Jonathan | General Counsel | Buy | 25,000 | $47,250 |
| 2026-02-10 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Sell | 36,687 | $239,199 |
| 2026-01-12 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Sell | 46,777 | $250,257 |
| 2026-01-05 | Schuetz Thomas J. | CEO | Buy | 250,000 | $1.3M |
| 2026-01-05 | Anderman Jonathan | General Counsel | Buy | 150,000 | $775,500 |
| 2026-01-05 | Shin Barry | CFO | Buy | 125,000 | $646,250 |
| 2026-01-05 | Lerner Neil | Chief Accounting Officer | Buy | 62,500 | $323,125 |
| 2025-11-18 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Sell | 44,025 | $212,641 |
| 2025-05-27 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $21,100 |
Source: SEC Form 4 filings · as of 2026-10-02